Esperion Therapeutics, Inc. 4

No insider securities transaction is reported; the document is a power of attorney authorization for future SEC ownership filings by Benjamin Looker related to Esperion Therapeutics, Inc.

This filing is not a Form 4 reporting an insider trade but rather a Limited Power of Attorney executed by Benjamin Looker on December 13, 2021, authorizing designated company officers to prepare and file his Section 16 and Schedule 13D ownership reports with the SEC on his behalf. It establishes who may sign future Forms 3, 4, 5, and Schedule 13D filings for him in his capacity as an officer and/or director of Esperion Therapeutics, Inc., but it does not disclose any actual insider purchase, sale, grant, or other transaction in the company’s securities.

Filing Facts

CIK

1434868

Ticker

ESPR

Form

4

Source Type

fda

Accession

0001628280-26-048001

Alert Tier

4